| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491271A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | CA2491002A1 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 01/08/2004 | CA2490811A1 Use of organic compounds |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490282A1 Use of casein peptides for treating hypertension |
| 01/08/2004 | CA2490138A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | CA2490130A1 Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489660A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | CA2489555A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2487712A1 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377834A2 Medicaments which are modulators of hm74 and/or hm74a activity |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377671A2 Oncolytic adenoviral vectors |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377575A1 Antiviral pyrazolopyridine compounds |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377570A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377545A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 01/07/2004 | EP1377543A1 Oxalic acid derivatives |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377308A1 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377303A2 Method for reducing cellular damage resulting from hypoxia/ischaemia-related inflammation |
| 01/07/2004 | EP1377300A1 Zinc ionophores as anti-stress agents |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377284A1 Controlled release arginine formulations |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1294388B1 Extracts from sophora species, method for producing the same and their use |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0944611B1 Dimesylate salts of neuropeptide y ligands |
| 01/07/2004 | EP0943334B1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0920326B1 Use of a bpi protein product as an antithrombotic agent |
| 01/07/2004 | EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466466A Remedies for heart failure |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465586A Cyclic Wushengtai and preparation process thereof |
| 01/07/2004 | CN1465570A Process for preparing genistein, medicinal composition and use thereof |
| 01/07/2004 | CN1465399A Lipid reducing and regulating agent |
| 01/07/2004 | CN1465393A Medical liquor for treating pile and preparation method thereof |
| 01/07/2004 | CN1465386A Chinese medicine preparation for treating cardio-cerebral vascular disease |
| 01/07/2004 | CN1465382A Medicine for non-operation treating of hernia |
| 01/07/2004 | CN1465377A Method for preparing oral medicine for treating pile |
| 01/07/2004 | CN1465373A Hypotensor medical threat for treating hypertension |
| 01/07/2004 | CN1465369A Chinese medicine Wuxingsan powder and its preparation method |
| 01/07/2004 | CN1465365A Hypotensor paint for curing hypertension |
| 01/07/2004 | CN1465352A Scorpion venom cral liquor |
| 01/07/2004 | CN1465350A Toad skin preparation and productive process thereof |
| 01/07/2004 | CN1465344A Medicine composition for treating myocardial ischemia, angina pectoris and cardiac infarction |
| 01/07/2004 | CN1465343A Medical cure use of 17-allyl-4,5ÔÇÿalphaÔÇÖ-epoxy-3, 14-dihydroxymorphinan-6 keto hydrochloride |
| 01/07/2004 | CN1133743C Modified clotting Factor VII |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133439C Use of exterior-applied medical liquid in preparation of medicine for treating pile |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/06/2004 | US6673968 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |